Nucleus | Jotup

Zendesk Users Report a 43% Lower Total Cost of Ownership than Salesforce According to Nucleus Research Report

Retrieved on:

Tuesday, January 23, 2024

Nucleus Research published a report assessing Zendesk user’s experience with the CRM platform to determine the incremental value of transitioning to Zendesk from Salesforce Service Cloud.

Key Points:

Nucleus Research published a report assessing Zendesk user’s experience with the CRM platform to determine the incremental value of transitioning to Zendesk from Salesforce Service Cloud.
Zendesk users reported the platform’s ease of use, platform adaptability and agility, and value delivered relative to cost were the primary components driving their selection.
Nucleus found these attributes translated to faster time to value, a 43 percent reduction in TCO, and elevated customer experience management.
Users report that the implementation of Zendesk is 53.7% faster than that of Salesforce Service Cloud.

New Study Further Demonstrates Value of Paycom’s Beti Payroll Solution

Retrieved on:

Thursday, January 18, 2024

Professional Services, Apps, Applications, Technology, Human Resources, Software, Internet, Nucleus, Organization, Automation, ROI

The commissioned study also found three typical benefit areas stemming from Paycom’s single HR software featuring Beti, including reduced errors, increased payroll productivity and improved employee engagement.

Key Points:

The commissioned study also found three typical benefit areas stemming from Paycom’s single HR software featuring Beti, including reduced errors, increased payroll productivity and improved employee engagement.
A leader within the restaurant industry told Nucleus the automation from Beti took days off payroll processing time.
“Beti is a paradigm shift for the payroll industry, and the value of perfect payroll is showing tremendous ROI for our clients,” said Chad Richison, founder, chairman and CEO of Paycom.
With Paycom’s payroll solution, clients reduced time spent processing payroll by upward of 90%.

Core Biogenesis and Nucleus Biologics Announce Strategic Collaboration for Manufacturing and Distribution of Cost-Effective and Sustainable Recombinant Proteins

Retrieved on:

Wednesday, January 10, 2024

Science, Biotechnology, Research, Other Manufacturing, Medical Supplies, Health, Genetics, Manufacturing, Core, CO2, Partnership, GMP, A-DNA, Protein, Nucleus, Plant, RUO

This agreement makes Nucleus Biologics the GMP manufacturer for Core Biogenesis’ recombinant proteins and a distributor for the cell and gene therapy market.

Key Points:

This agreement makes Nucleus Biologics the GMP manufacturer for Core Biogenesis’ recombinant proteins and a distributor for the cell and gene therapy market.
In addition, Nucleus Biologics, along with their sister company Stoic Bio , will make these recombinant proteins available for their Krakatoa™ pod-based media manufacturing systems.
Nucleus Biologics and Core Biogenesis are poised to demonstrate that developing and manufacturing lifesaving therapies doesn’t have to come with a heavy environmental cost.
The Core Biogenesis and Nucleus Biologics collaboration will create a truly unique service offering that will introduce a paradigm shift in development and manufacturing to the entire industry.

Bread Financial Achieves 75% ROI by Implementing BrightPlan According to Nucleus Research ROI Case Study

Retrieved on:

Wednesday, January 10, 2024

Professional Services, Data Analytics, Technology, Human Resources, Software, Finance, Internet, Nucleus, Workforce, Retirement, Death, Research, Bread Financial, ROI

Nucleus Research announced the findings of a study into the benefits that financial services provider, Bread Financial realized from implementing financial wellness solution, BrightPlan .

Key Points:

Nucleus Research announced the findings of a study into the benefits that financial services provider, Bread Financial realized from implementing financial wellness solution, BrightPlan .
This delivered a 75 percent Return on Investment (ROI) for Bread Financial who was able to recover its initial investment in the solution just 2.1 years after deployment.
We began searching for a better suited financial wellness offering with the goal of improving associate experience and reducing financial stressors across our workforce,” said a spokesperson from Bread Financial.
Upon the implementation of BrightPlan, Bread Financial was able to reduce its annual turnover rate by 22%, retaining approximately 336 associates annually.

Nucleus RadioPharma Appoints Former McKesson, Novo Nordisk Executive Kathy Spencer-Pike as Chief Commercial Officer to Drive Business Growth

Retrieved on:

Thursday, December 14, 2023

Biotechnology, Radiology, Health, Oncology, Erg, Organization, ERG, Sanofi, Nucleus, Multimedia, Patient, Radiopharmaceutical, Growth, Novo Nordisk, McKesson Corporation, Pharmaceutical industry, Pfizer

Nucleus RadioPharma , the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, today announced the appointment of Kathy Spencer-Pike as Chief Commercial Officer.

Key Points:

Nucleus RadioPharma , the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, today announced the appointment of Kathy Spencer-Pike as Chief Commercial Officer.
As a seasoned veteran with decades of commercial experience at McKesson, Novo Nordisk, Sanofi and Pfizer, Ms. Spencer-Pike will be responsible for accelerating the growth of the startup following its oversubscribed $56M Series A in October.
Ms. Spencer-Pike follows a string of C-Suite appointments including Geoff Johnson, M.D., Ph.D. as Chief Scientific Officer, Kevin Haehl as Chief Development Officer and Mark Przekop as Chief Operating Officer.
Ms. Spencer-Pike previously was VP, Commercial Leader for Novo Nordisk, successfully leading the planning, development and execution of market and sales strategies, exceeding revenue goals.

Nucleus Research Unveils Hot Companies To Watch in 2024

Retrieved on:

Tuesday, December 5, 2023

Consulting, Data Analytics, Professional Services, Business, Nucleus, Organization, Research

Nucleus Research announced its top 10 companies predicted to advance in 2024.

Key Points:

Nucleus Research announced its top 10 companies predicted to advance in 2024.
In identifying the hot companies, Nucleus considered each vendor according to how well they were able to implement strategies that continue to add value for customers and produce valuable business outcomes.
This year’s list includes both more recent market entrants addressing specialty organizational difficulties as well as well-established leaders in particular fields.
“Though there’s uncertainty surrounding the economy as we head into 2024, a number of vendors stand out for the exceptional value they provide to their customers,” said Ian Campbell , CEO of Nucleus Research.

HARMAN Acquires Roon, a popular Multi-Device, Multi-Room Audio Technology Platform

Retrieved on:

Monday, November 27, 2023

Roon is available for all popular operating systems and manufactures a line of hardware server appliances called Nucleus.

Key Points:

Roon is available for all popular operating systems and manufactures a line of hardware server appliances called Nucleus.
“At HARMAN we take great pride in our ability to create exceptional audio experiences for our partners and consumers around the world,” said Dave Rogers, President, Lifestyle Division, HARMAN.
Aligned with its ‘work with all’ strategy, HARMAN is committed to growing Roon’s open device ecosystem which includes collaborating with more than 160 other audio brands, delivering audio to more than 1000 high-performance devices.
“Our team is ecstatic to join HARMAN, a visionary company that has been leading the audio industry forward for decades,” said Enno Vandermeer, CEO of Roon.

Epicor Recognized as a Leader in the Nucleus Research CPQ Technology Value Matrix 2023

Retrieved on:

Thursday, November 16, 2023

Networks, Internet, Data Management, Technology, Software, Cloud, CPQ, Nucleus, Mom, Sales, Epicor

Epicor, a global leader of industry-specific enterprise software to promote business growth, today announced that for the second time in a row it has been positioned as a Leader in the Nucleus Research Configure Price Quote (CPQ) Technology Value Matrix published in November 2023.

Key Points:

Epicor, a global leader of industry-specific enterprise software to promote business growth, today announced that for the second time in a row it has been positioned as a Leader in the Nucleus Research Configure Price Quote (CPQ) Technology Value Matrix published in November 2023.
Nucleus evaluated Epicor CPQ , a comprehensive solution that streamlines the quoting process by automating configuration, pricing, and quoting.
Epicor CPQ can be used as a standalone product or integrated with the Epicor Industry ERP Cloud.
“Customers choose Epicor CPQ for an end-to-end solution that will drive customer engagement and help boost revenues,” said Vaibhav Vohra, Chief Product and Technology Officer at Epicor.

SHINE Technologies and Nucleus RadioPharma Partner to Advance Radioligand Cancer Treatments

Retrieved on:

Thursday, November 16, 2023

View the full release here: https://www.businesswire.com/news/home/20231116001648/en/

Key Points:

View the full release here: https://www.businesswire.com/news/home/20231116001648/en/
Under the multi-year agreement, SHINE will provide lutetium-177, a vital component in cutting-edge medical treatments, to Nucleus RadioPharma's radioligand therapy (RLT) offerings for targeted radiopharmaceutical treatments for neuroendocrine tumors and prostate cancer.
Nucleus RadioPharma was founded to build reliable clinical and commercial supply chains for targeted radiotherapies, including radioligand therapy.
"We are pleased to partner with SHINE, allowing us to utilize its dependable supply of lutetium-177 to develop highly effective treatments for cancer patients.
“We are proud to partner with Nucleus RadioPharma to supply the high-purity lutetium-177 that powers their innovative radioligand therapy,” said Harrie Buurlage, Chief Commercial Officer of Isotopes at SHINE Technologies.

Infor Positioned as a Leader in the Nucleus WMS Technology Value Matrix 2023

Retrieved on:

Thursday, November 30, 2023

WCS, Architecture, ROI, Infor, Workforce, Nucleus, KPI, Intelligence, Machine learning, RPA, ERPs, Waveless order fulfillment, Inline, API, OS, Robotics, WMS, Warehouse, Online shopping

NEW YORK, Nov. 30, 2023 /PRNewswire/ -- Infor®, the industry cloud company, today announced that Nucleus Research has positioned Infor as a Leader in its WMS Technology Value Matrix 2023. Infor is recognized for its strong WMS platform with a wide range of capabilities, including newly integrated machine learning.

Key Points:

NEW YORK, Nov. 30, 2023 /PRNewswire/ -- Infor®, the industry cloud company, today announced that Nucleus Research has positioned Infor as a Leader in its WMS Technology Value Matrix 2023.
"Infor is proud to be placed in the leader quadrant of the Nucleus WMS Value Matrix.
Download a complimentary copy of the 2023 Nucleus Research WMS Technology Value Matrix.
The Nucleus Research WMS Technology Value Matrix is a concise assessment of the operational value a solution delivers.